Johnson & Johnson Healthcare - Medical Equipment SWOT Report

Summary

Johnson & Johnson - Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company's business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company's performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Scope

• Critical appraisal of the company's positioning using SWOT analysis.
• Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.

Reasons to buy

• Support business/sales activities by understanding customers businesses better.
• Identify prospective partners and suppliers.
• Capitalize on your competitors weaknesses and target the market opportunities available to them.

Contents

• 1 List of Tables
• 2 Company Snapshot
  • 2.1 Key Information
  • 2.2 Company Overview
  • 2.3 Financial Performance
  • 2.4 Industry Outlook - Cardiovascular Devices
  • 2.5 Industry Outlook - Orthopedic Devices
  • 2.6 Industry Outlook - Hospital Supplies
• 3 Business Description
  • 3.1 Business Overview
  • 3.2 Consumer
    • 3.2.1 Overview
    • 3.2.2 Financials
    • 3.2.3 Market View
    • 3.2.4 Key Strategies
  • 3.3 Medical Devices and Diagnostics
    • 3.3.1 Overview
    • 3.3.2 Financials
    • 3.3.3 Market View
    • 3.3.4 Key Strategies
  • 3.4 Pharmaceutical
    • 3.4.1 Overview
    • 3.4.2 Financials
    • 3.4.3 Market View
    • 3.4.4 Key Strategies
  • 3.5 Major Products and Services
    • 3.5.1 Overview
• 4 History
• 5 SWOT Analysis
  • 5.1 Overview
  • 5.2 Johnson & Johnson Strengths
    • 5.2.1 Strong presence in oncology market
    • 5.2.2 Financial strength
    • 5.2.3 Strong brand value
  • 5.3 Johnson & Johnson Weaknesses
    • 5.3.1 Few novel products
    • 5.3.2 Underperformance of pharmaceutical division
    • 5.3.3 Concentrated revenues
  • 5.4 Johnson & Johnson Opportunities
    • 5.4.1 Acquisitions
    • 5.4.2 Growing U.S. market
    • 5.4.3 Approval of Perzista
  • 5.5 Johnson & Johnson Threats
    • 5.5.1 Mergers and acquisitions
    • 5.5.2 Increased competition due to patent expiry
    • 5.5.3 Generic competition to Topamax
• 6 Competitors
• 7 Key Employees
• 8 Key Employee Biographies
• 9 Company Statement
• 10 Locations And Subsidiaries
  • 10.1 Head Office
  • 10.2 Other Locations & Subsidiaries
• 11 Recent Developments
  • 11.1 Strategy And Business Planning
    • 11.1.1 Jan 07, 2008: Johnson & Johnson To Expand Into Indian Orthopedic Devices Market
  • 11.2 Financial Announcements
    • 11.2.1 Jul 15, 2008: Johnson & Johnson Declares 2Q 2008 Results
    • 11.2.2 Apr 24, 2008: Johnson & Johnson Announces Dividend Increase Of 10.8%
    • 11.2.3 Apr 15, 2008: Johnson & Johnson Declares Q1 2008 Results
    • 11.2.4 Jan 22, 2008: Johnson & Johnson Declares Q4 2007 Results
    • 11.2.5 Oct 16, 2007: Johnson & Johnson Declares Q3 2007 Results
    • 11.2.6 Jul 17, 2007: Johnson & Johnson Declares Q2 2007 Results
    • 11.2.7 Jul 09, 2007: Johnson & Johnson Announces Shares Repurchase Program
    • 11.2.8 Apr 17, 2007: Johnson & Johnson Declares Q1 2007 Results
    • 11.2.9 Jan 23, 2007: Johnson & Johnson Declares Q4 2006 Results
    • 11.2.10 Oct 17, 2006: Johnson & Johnson Declares Q3 2006 Results
  • 11.3 Corporate Communications
    • 11.3.1 Jun 12, 2007: Johnson & Johnson Appoints New Director
  • 11.4 Legal and Regulatory
    • 11.4.1 Aug 05, 2008: Johnson & Johnson Receives US Subpoena On Bile-Duct Stents
    • 11.4.2 Jul 11, 2008: Amgen Settles Antitrust Law Suit With Ortho Biotech
    • 11.4.3 Jun 17, 2008: Johnson & Johnson Resolves Lawsuit With American Red Cross
    • 11.4.4 Jul 19, 2007: Ortho-McNeil Settles Litigation With Par
• 12 Appendix
  • 12.1 Methodology
  • 12.2 About Global Markets Direct
  • 12.3 Contact Us
  • 12.4 Disclaimer
• 1 List of Tables
  • Table 1: Johnson & Johnson,Key Facts, 2007
  • Table 2: Johnson & Johnson, SWOT Analysis , 2007
  • Table 3: Johnson & Johnson, Key Employees, 2007
  • Table 4: Johnson & Johnson, Subsidiaries